Participants Needed: Have your say in the evaluation of CAR T-Cell Therapy

Stakeholder engagement in an economic evaluation of CAR-T cell therapy: improving economic evaluation with stakeholder-specific input

 Principal Investigator: Dr. Justin Presseau

Co-Principal Investigators: Dr. Kednapa Thavorn

Co-Investigators: Dr. Natasha Kekre, Dr. Harry Atkins, Dr. Doug Coyle, Dr. Dean Fergusson, Mr. Terry Hawrysh, Dr. Ian Graham, Dr. Brian Hutton, Dr. Jeremy Grimshaw, Dr. Manoj Lalu

We want to hear from healthcare professionals, researchers, patients and families

We are looking for volunteers to take part in a study to gather feedback and views from a range of people and perspectives as we develop an evaluation of the costs and benefits of a new immunotherapy for blood cancer treatment, Chimeric Antigen Receptor (CAR) T-cell Therapy.

Our research team includes researchers, physicians, patients and health economists who are interested in understanding your views and experiences related to blood cancer treatments. You are being asked whether you would like to take part in a group discussion led by a member of our research team. The discussion will last between two and three hours and will be scheduled at a time and place reflective of participant interest. You will be provided with an Amazon gift card for $10 CAD following completion of an online stakeholder group discussion feedback form which should take approximately 5 minutes to complete.

Participation in this study is voluntary. If you have any questions or if you are interested in participating, please contact the study Research Assistant, Mackenzie Wilson at macwilson@ohri.ca or at 613-737-8899 ext. 73813.